Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells
- Type
- Retraction
- Notice date
- 7/3/2023 0:00
- Journal
- Oncology Letters
- Publisher
- Spandidos
- Notice DOI
- 10.3892/ol.2023.13938
- Original paper DOI
- 10.3892/ol.2017.6597
Reasons
- Concerns/Issues about Image
- Duplication of/in Image
- Euphemisms for Duplication
- Investigation by Journal/Publisher
- Unreliable Data